Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 2/2008

01-03-2008 | Original Article

1,161 patients with adrenal incidentalomas: indications for surgery

Authors: A. A. Kasperlik-Załuska, M. Otto, A. Cichocki, E. Rosłonowska, J. Słowinska-Srzednicka, W. Zgliczyński, W. Jeske, L. Papierska, T. Tołłoczko, J. Polański, R. Słapa

Published in: Langenbeck's Archives of Surgery | Issue 2/2008

Login to get access

Abstract

Background and aims

The aim of this study is to analyze the clinical data and criteria for surgery in a group of over 1,100 patients with adrenal incidentalomas (AI) observed at the Department of Endocrinology.

Patients and methods

The material consisted of 1,161 patients (842 women and 319 men, 10–87 years old) with AI ranging in size from 1.0 to 23.0 cm. The methods included clinical examination, imaging studies, hormonal determinations in the blood and in the urine as well as histological and immunocytochemical investigations in 390 patients treated by surgery.

Results

Basing on these studies, we diagnosed 112 patients with primary malignant adrenal tumors (100 with carcinoma), 45 with metastatic infiltrations, and 1,004 with probable benign AI. Imaging phenotypes (especially high density on computed tomography, CT) were characteristic of malignant and chromaffin tumors. Subclinical adrenal hyperactivity was found in 8% of the patients with pre-Cushing’s syndrome as the most frequent form (6.5%). Chromaffin tumors were detected in 3%.

Conclusions

(1) Indications for surgery include malignant tumors (both primary and metastatic), tumors with subclinical hyperfunction, and chromaffin tumors. High density on CT, >20 HU, appeared to be an important indication for surgery. (2) A slight prevalence of oncological indications over endocrinological indications (14 vs. 11%) was found.
Literature
1.
go back to reference Kasperlik-Załuska AA, Migdalska B, Jeske W, Tołłoczko T, Szamowska R, Leowska E, Słowińska-Srzednicka J, Rosłonowska E, Misiorowski W (1992) Incidentally found adrenal tumors: Results of investigation of the pituitary–adrenal axis. Endokr Pol 43:322–329PubMed Kasperlik-Załuska AA, Migdalska B, Jeske W, Tołłoczko T, Szamowska R, Leowska E, Słowińska-Srzednicka J, Rosłonowska E, Misiorowski W (1992) Incidentally found adrenal tumors: Results of investigation of the pituitary–adrenal axis. Endokr Pol 43:322–329PubMed
2.
go back to reference Kasperlik-Załuska AA, Rosłonowska E, Słowińska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H (1997) Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol 46:29–37CrossRef Kasperlik-Załuska AA, Rosłonowska E, Słowińska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H (1997) Incidentally discovered adrenal mass (incidentaloma): investigation and management of 208 patients. Clin Endocrinol 46:29–37CrossRef
3.
go back to reference Angeli A, Osella G, Ali A, Terzolo M (1997) An overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 47:279–283PubMedCrossRef Angeli A, Osella G, Ali A, Terzolo M (1997) An overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 47:279–283PubMedCrossRef
4.
go back to reference Kievit J, Haak HR (2000) Diagnosis and treatment of adrenal incidentaloma: a cost-effectiveness analysis. Endocrinol Metab Clin North Am 29:69–90PubMedCrossRef Kievit J, Haak HR (2000) Diagnosis and treatment of adrenal incidentaloma: a cost-effectiveness analysis. Endocrinol Metab Clin North Am 29:69–90PubMedCrossRef
5.
go back to reference Schteingart DE (2000) Management approaches to adrenal incidentalomas: a view from Ann Arbor, Michigan. Endocrinol Metab Clin North Am 29:127–139PubMedCrossRef Schteingart DE (2000) Management approaches to adrenal incidentalomas: a view from Ann Arbor, Michigan. Endocrinol Metab Clin North Am 29:127–139PubMedCrossRef
6.
go back to reference Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 85:637–644PubMedCrossRef Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A (2000) A survey on adrenal incidentaloma in Italy. J Clin Endocrinol Metab 85:637–644PubMedCrossRef
7.
go back to reference Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P, Sartorio A, Faglia G (1995) Abnormalities of endocrine function in patients with clinically “silent” adrenal masses. Eur J Endocrinol 132:422–428PubMed Ambrosi B, Peverelli S, Passini E, Re T, Ferrario R, Colombo P, Sartorio A, Faglia G (1995) Abnormalities of endocrine function in patients with clinically “silent” adrenal masses. Eur J Endocrinol 132:422–428PubMed
8.
go back to reference Young WF Jr (2004) Adrenal incidentaloma MTP. ENDO, New Orleans, pp. 7–15 Young WF Jr (2004) Adrenal incidentaloma MTP. ENDO, New Orleans, pp. 7–15
9.
go back to reference Young WF Jr (2000) Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185PubMedCrossRef Young WF Jr (2000) Management approaches to adrenal incidentalomas: a view from Rochester, Minnesota. Endocrinol Metab Clin North Am 29:159–185PubMedCrossRef
10.
go back to reference Bernini G, Moretti A, Argenio G, Salvetti A (2002) Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol 146:523–529PubMedCrossRef Bernini G, Moretti A, Argenio G, Salvetti A (2002) Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol 146:523–529PubMedCrossRef
11.
go back to reference Kasperlik-Zaluska AA, Slowinska-Srzednicka J (2000) Adrenal response to glucocorticoid treatment. Lancet 355:1458–1459 Kasperlik-Zaluska AA, Slowinska-Srzednicka J (2000) Adrenal response to glucocorticoid treatment. Lancet 355:1458–1459
12.
go back to reference Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667–680PubMedCrossRef Schteingart DE, Doherty GM, Gauger PG, Giordano TJ, Hammer GD, Korobkin M, Worden FP (2005) Management of patients with adrenal cancer: recommendations of an international consensus conference. Endocr Relat Cancer 12:667–680PubMedCrossRef
13.
go back to reference Kasperlik-Zaluska AA, Cichocki A (2005) Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up. J Experim Therap Oncol 5:125–132 Kasperlik-Zaluska AA, Cichocki A (2005) Clinical role of determination of plasma mitotane and its metabolites levels in patients with adrenal cancer: results of a long-term follow-up. J Experim Therap Oncol 5:125–132
14.
15.
Metadata
Title
1,161 patients with adrenal incidentalomas: indications for surgery
Authors
A. A. Kasperlik-Załuska
M. Otto
A. Cichocki
E. Rosłonowska
J. Słowinska-Srzednicka
W. Zgliczyński
W. Jeske
L. Papierska
T. Tołłoczko
J. Polański
R. Słapa
Publication date
01-03-2008
Publisher
Springer-Verlag
Published in
Langenbeck's Archives of Surgery / Issue 2/2008
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-007-0238-6

Other articles of this Issue 2/2008

Langenbeck's Archives of Surgery 2/2008 Go to the issue